Basic Fibroblast Growth Factor in a Carboxymethylcellulose Vehicle Reverses the Bacterial Retardation of Wound Contraction

Wounds

Volumn 13, Issue 2, 2000, Pages 73-80

  Kuhn, Ann ^b   Page, Lance ^b   Nguyen, Keoni ^b   Ko, Francis ^b   Wang, Xue ^b   Wachtel, T L ^b   Robson, M C ^a  

^a Bay Pines VA Medical Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0346972155     PISSN: 10447946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Lazarus GS, Cooper DM, Knighton DR, et al. Definitions and guidelines for assessment of wounds and evaluation of healing. Arch Dermatol 1994;130:489-93.
2. Bennett NT, Schultz GS. Growth factors and wound healing: Biochemical properties of growth factors and their receptors. Am J Surg 1993;165:728-37.
3. Steed DL. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic ulcer study group. J Vasc Surg 1995;21:71-81.
4. Robson MC. Exogenous growth factor application effect on human wound healing. Prog Derm 1996;30:1-6.
5. Tarnuzzer RW, Schultz GS. Biochemical analysis of acute and chronic wound environments. Wound Rep Regen 1996; 4:321-5.
6. Robson MC. Wound infection: A failure of wound healing caused by an imbalance of bacteria. Surg Clin NA 1997; 77: 637-50.
7. Stadelmann WK, Digenis AG, Tobin GR. Impediments to wound healing. Am J Surg 1998;176(Suppl 2A):39S-47S.
8. Bennett NF, Schultz GS. Growth factors and wound healing: Part II. Role in normal and chronic wound healing. Am J Surg 1993; 166:74-81.
9. Perry AW, Sutkin HS, Gottlieb LD, et al. Skin graft survival - The bacterial answer. Ann Plast Surg 1989;22:479-83.
10. Peacock EE. Wound Repair, Third Edition. Philadelphia, PA: Saunders, 1984:38-55.
11. Bhora FY, Dunkln BJ, Batzri S, et al. Effect of growth factors on cell proliferation and epithelialization in human skin. J Surg Res 1995;59:236-44.
12. Gibran NS, Isik FF, Heimbach DM, Gordon D. Basic fibroblast growth factor in the early human burn wound. J Surg Res 1995;56:226-34.
13. Montesano R, Vassalli JD, Baird A, et al. Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci USA 1986;83:7297-301.
14. Baird A, Walicke PA. Fibroblast growth factor. Br Med Bull 1989;45:438-52.
15. Lindner V, Lappi DA, Baird A, et al. Role of basic fibroblast growth factor in vascular lesion formation. Circ Res 1991;86:106-13.
16. Gospodarowicz D, Plotiet J, Malerstein J, et al. Comparison of the ability of basic and acidic fibroblast growth factor to stimulate the proliferation of an established keratinocyte cell line. J Cell Physiol 1990;145:1023-29.
17. Rapraeger AC, Krufka A, Olwin BB. Requirements of heparan sulfate for bFGF-mediated fibroblast growth and myofibroblast differentiation. Science 1991;252:1705-8.
18. Hoppenreijs VP, Pels E, Vrensen GF, Treffers WF. Basic fibroblast growth factor stimulates corneal endothelial cell growth and endothelial wound healing of human corneas. Invest Ophthalmol Vis Sci 1994;35:931-44.
19. Alberts GF, Hsu DK, Peifley KA, Winkles JA. Differential regulation of acidic and basic fibroblast growth factor gene expression in fibroblast growth factor-treated rat aortic smooth muscle cells. Circ Res 1994;75:261-7.
20. Wang D, Mayo MW, Baldwin AS Jr. Basic fibroblast growth factor transcriptional autoregulation requires EGF-1. Oncogene 1997;14:2291-9.
21. Roesel JF, Nanney LB. Assessment of different cytokine effects on angiogenesis using an in-vivo model of cutaneous wound repair. J Surg Res 1995;58:449-59.
22. Danilenko DM, Ring BD, Tarpley JE, et al. Growth factors in porcine full and partial thickness burn repair: Differing targets and effects of keratinocyte growth factor, platelet-derived growth factor-BB, epidermal growth factor, and neu differentiation factor. Am J Pathol 1995;147:1261-77.
23. Nicosia R, Nicosia S, Smith M. Vascular endothelial growth factor, platelet-derived growth factor, and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro. Am J Path 1994;145:1023-9.
24. Fu X, Shen Z, Chen Y, et al. Randomized placebocontrolled trial of use of topical recombinant bovine basic fibroblast growth factor for seconddegree burns. Lancet 1998;352:1661-4.
25. Uhl E, Barker JH, Bondar I, et al. Basic fibroblast growth factor accelerates wound healing in chronically ischaemic tissue. Br J Surg 1993;80:977-80.
26. McGee GS, Davidson JM, Buckley A, et al. Recombinant basic fibroblast growth factor accelerates wound healing. J Surg Res 1988;45:145-53.
27. Broadley KN, Aquino AM, Woodward SC, et al. Monospecific antibodies implicate basic fibroblast growth factor in normal wound repair. Lab Invest 1989;61:571-5.
28. Phillips LG, Geldner P, Brou J, et al. Correction of diabetic incisional wound impairment with basic fibroblast growth factor. Surg Forum 1990;41:602-3.
29. Broadley KN, Aquino AM, Hicks B, et al. Growth factors basic fibroblast growth factor and TGF beta accelerate the rate of wound repair in normal and in diabetic rats. Int J Tissue React 1988;6:345-53.
30. Klingbeil CK, Cesar LB, Fiddes JC. Basic fibroblast growth factor: Effects on tissue repair in models of impaired wound healing. In: Barbul A, Caldwell M, Eaglstein W, et al. (eds). Clinical and Experimental Approaches to Dermal and Epidermal Repair: Normal and Chronic Wounds. New York, NY: Alan R. Liss, 1991;443-50.
31. Davidson JM, Bradley KN, Quaglino D. Reversal of the wound healing deficit in diabetic rats by combined basic fibroblast growth factor and transforming growth factor-β1 therapy. Wound Rep Regen 1997; 5:77-88.
32. Sprugel KH, McPherson JM, Clowes AW, Ross R. Effect of growth factors in vivo. Am J Pathol 1987;129:601-11.
33. Robson MC, Phillips LG, Lawrence WT, et al. The safety and effect of topically applied recombinant basic fibroblast growth factor on healing of chronic pressure sores. Ann Surg 1992;216:401-8.
34. Robson MC, Hill DP, Smith PD, et al. Sequential cytokine therapy for pressure ulcers: Clinical and mechanistic response. Ann Surg 2000;231:600-11.
35. Hayward P, Hokanson J, Heggers J, et al. Fibroblast growth factor reverses the bacterial retardation of wound contraction. Am J Surg 1992;163:288-93.
36. Hayward PG, Robson MC. Animal models of wound contraction. In: Barbul A, Caldwell M, Eaglstein W, et al. (eds). Clinical and Experimental Approaches to Dermal and Epidermal Repair: Normal and Chronic Wounds. New York, NY: Alan R. Liss, 1991;301-12.
37. Robson MC, Krizek TJ. The effect of human amniotic membranes on the bacterial population of infected rat burns. Ann Surg 1973;177:144-9.
38. Robson MC, Edstrom LE, Krizek TJ, Groskin MG. The efficacy of systemic antibiotics in the treatment of granulating wounds. J Surg Res 1984;16:299-306.
39. Heggers JP. Variations on a theme. In: Heggers JP, Robson MC, (eds). Quantitative Bacteriology: Its Role in the Armamentarium of the Surgeon. Boca Raton, FL: CRC Press, 1991.
40. Stadelmann WK, Digenis AG, Tobin GR. Physiology and healing dynamics of chronic cutaneous wounds. Am J Surg 1998;176(Suppl 2A):26S-38S.
41. Mast BA, Schultz GS. Interactions of cytokines, growth factors, and proteases in acute and chronic wounds. Wound Rep Regen 1996;4: 411-20.
42. Tarnuzzer RW, Macauley SP, Mast BA, et al. Epidermal growth factor in wound healing: A model for the molecular pathogenesis of chronic wounds. In: Ziegler T, Pierce G, Herndon D (eds). Growth Factors and Wound Healing. New York, NY: Springer Verlag, 1997;206-28.
43. Stenberg BD, Phillips LG, Hokanson JA, Heggers JP, Robson MC. Effect of bFGF on the inhibition of contraction caused by bacteria. J Surg Res 1991;50:47-50.
44. Greenhalgh DG, Sprugel KH, Murray MJ, Ross R. PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am J Pathol 1990;136:1235-46.
45. Laxarou SA, Efron JE, Shaw T, et al. Fibroblast growth factor inhibits wound collagen synthesis. Surg Forum 1989;40:627-9.
46. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987;235:442-7.
47. Gospodarowicz D, Baird A, Cheng J, et al. Isolation of fibroblast growth factor from bovine adrenal gland: Physicochemical and biological characterization. Endocrinology 1986;118:82-90.
48. Gospodarowicz D, Bialecki H, Thakral TK. The angiogenic activity of fibroblast and epidermal growth factor. Exp Eye Res 1989;28:501-14.
49. d'Hemecourt PA, Smiell JM, Karim MR. Sodium carboxymethylcellulose aqueous-based gel vs. becaplermin gel in patients with nonhealing lower extremity diabetic ulcers. WOUNDS 1998;10:69-75.
50. Castronuovo, JJ, Ghobriel, I, Giusti, AM, et al. Effects of chronic wound fluid on the structure and biological activity of becaplermin (rhPDGFBB) and becaplermin gel. Am J Surg 1998;176 (Suppl 2A):61S-67S.
51. Banda MF, Dwyer KS, Beckmann A. Wound fluid angiogenesis factor stimulates the directed migration of capillary endothelial cells. J Cell Biochem 1985;29:183-93.